2022Verhoef L, et al.Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.
2022Tewari SR, et al.Association of Plasma Circulating Tumor HPV DNA With HPV-Related Oropharynx Cancer.
2022Pedersen H, et al. Clinical Performanceof the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework.
2022Niemeyer-van der Kolk T, et al. Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.
2022King CHS 4th, et al. Communicating regulatory high-throughput sequencing data using BioCompute Objects. Drug Discov Today.
2022Ghorzang E, et al. HPV type-specific distribution among family members and linen in households of cutaneous wart patients.
2022de Geus V, et al. IdentifyingMolecular Changes in Early Cervical Cancer Samples of Patients That Developed Metastasis.
2022Bibby DC, et al. Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition Assays.
2022Aknouch I, et al. Human milk inhibits some enveloped virus infections, including SARS-CoV-2, in an intestinal model.
2022Hu SY, et al. Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial.
2022Armando F, et al. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
2022Du W, et al. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern.
2022Wahid R, et al. Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children.
2022van den Tweel MM, et al. The relationship between vaginal pH and bacterial vaginosis as diagnosed using qPCRin an asymptomatic subfertile population.
2022Sierra MS, et al. Analysis of cervical HPVinfections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial.
2022Pagan L, et al. Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.
2022Mena M, et al. Concordance ofp16INK4a and E6*I mRNA among HPV-DNA-Positive Oropharyngeal,Laryngeal, and Oral Cavity Carcinomas from the ICO International Study.
2022Hammer A, et al. Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia.
2022Du W, et al. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern. Sci Immunol.
Reach out to our experts and see how we can help advance your clinical trialContact Us